Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03895684
Brief Title: Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors

First Submitted : February 14, 2019
First Submitted that Met QC Criteria : March 28, 2019
First Posted : March 29, 2019

Last Update Submitted that Met QC Criteria : March 17, 2021
Last Update Posted : March 18, 2021